Blood profile of oral mucosal disease patients with both vitamin B12 and iron deficiencies  by Chang, Julia Yu-Fong et al.
Journal of the Formosan Medical Association (2015) 114, 532e538Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.j fma-onl ine.comORIGINAL ARTICLEBlood profile of oral mucosal disease
patients with both vitamin B12 and iron
deficiencies
Julia Yu-Fong Chang a,b, Yi-Ping Wang a,b, Yang-Che Wu a,b,
Shih-Jung Cheng a,b, Hsin-Ming Chen a,b,c, Andy Sun a,b,*a Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei,
Taiwan
b Department of Dentistry, National Taiwan University Hospital, College of Medicine, National Taiwan
University, Taipei, Taiwan
c Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University, Taipei, TaiwanReceived 7 February 2015; received in revised form 10 March 2015; accepted 17 March 2015KEYWORDS
gastric parietal cell
antibody;
iron deficiency;
macrocytosis;
mean corpuscular
volume;
microcytosis;
vitamin B12 deficiencyConflicts of interest: The authors
* Corresponding author. Department
E-mail address: andysun7702@yah
http://dx.doi.org/10.1016/j.jfma.201
0929-6646/Copyright ª 2015, ElsevierBackground/Purpose: Vitamin B12 and iron deficiencies lead to macrocytosis [mean corpus-
cular volume (MCV)  100 fL] and microcytosis (MCV < 80 fL), respectively. This study evalu-
ated anemic status, MCV, serum homocysteine level, and serum gastric parietal cell antibody
(GPCA) level in oral mucosal disease patients with both vitamin B12 and iron deficiencies.
Methods: The blood hemoglobin (Hb), iron, vitamin B12, folic acid and homocysteine concen-
trations, MCV, and serum GPCA in 149 patients with both vitamin B12 and iron deficiencies were
measured and compared with the corresponding data in 149 age- and sex-matched healthy
control subjects.
Results: We found that 54 (36.2%), 16 (10.7%), 44 (29.5%), and 36 (24.2%) patients with both
vitamin B12 and iron deficiencies had Hb deficiency (men <13 g/dL, women <12 g/dL), folic
acid deficiency ( 6 mg/mL), abnormally high blood homocysteine level (>12.6 mM), and serum
GPCA positivity, respectively. Patients with both vitamin B12 and iron deficiencies had a signif-
icantly higher frequency of Hb deficiency, abnormally elevated blood homocysteine level, and
serum GPCA positivity than healthy control subjects (all p values < 0.001). Of 149 patients with
both vitamin B12 and iron deficiencies, 10 (6.7%) had high MCV ( 100 fL), 108 (72.5%) had
normal MCV (between 80 fL and 99 fL), and 31 (20.8%) had low MCV (<80 fL).
Conclusion: Approximately 73%, 30%, and 24% of patients with both vitamin B12 and iron defi-
ciencies are found to have normal MCV, abnormally high blood homocysteine level, and serum
GPCA positivity, respectively.
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Vitamin B plays an important role in hemoglobin (Hb),12
DNA synthesis, and cell division. Patients with vitamin B12
deficiency may have Hb deficiency and macrocytosis (mean
corpuscular volume [MCV]  100 fL) that eventually leads
to pernicious anemia.1,2 Vitamin B12 deficiency may be due
to an inadequate intake of vitamin B12-containing foods,
food-bound vitamin B12 malabsorption, lack of intrinsic
factor or parietal cells, ileal malabsorption in patients
with enteritis or ileal resection, biologic competition
including bacterial overgrowth and tapeworm infestation,
and defective transport such as transcobalamin II defi-
ciency.2 The intrinsic factor, which is produced by the
parietal cells of the stomach lining, can tightly bind to
dietary vitamin B12. The vitamin B12-intrinsic factor com-
plex is carried to the terminal ileum, where it is absorbed
after binding to intrinsic factor receptors on the luminal
membranes of ileal cells.1,2 Vitamin B12 deficiency may
lead to pernicious anemia. In pernicious anemia patients,
there are two mechanisms that cause the intrinsic factor
deficiency or inactivation. Firstly, about 85% of pernicious
anemia patients possess gastric parietal cell antibodies
(GPCA), which induce destruction of parietal cells and in
turn result in the failure of intrinsic factor production.3,4
Secondly, 40e80% of pernicious anemia patients have
intrinsic factor antibodies that bind to the vitamin B12-
binding site of the intrinsic factor and subsequently inac-
tivate the vitamin B12 absorption-aiding function of the
intrinsic factor.1,5
Iron is an essential element for Hb synthesis. Lack of iron
in the body may cause iron deficiency anemia which is a
kind of microcytic anemia (MCV < 80 fL).6,7 The causes of
iron deficiency include chronic blood loss associated with
excessive menstrual flow or gastrointestinal diseases such
as peptic ulcer, diverticulosis, or malignancies, consump-
tion of iron-poor foods, or a reduced absorption of iron in
patients with total gastrectomy or celiac sprue.6,7
In our oral mucosal disease clinic, there are many pa-
tients with burning mouth syndrome (BMS), recurrent
aphthous ulcerations (RAU), atrophic glossitis (AG), or oral
lichen planus (OLP). For these patients, a complete blood
count and examination of serum iron, vitamin B12, folic
acid, and homocysteine levels are usually ordered to check
whether these patients have microcytic or macrocytic
anemia, thalassemia, and deficiencies of hematinics.8e14
Although not often encountered, patients with both
vitamin B12 and iron deficiencies are sometimes discovered
in our oral mucosal disease clinic. Because vitamin B12
deficiency may result in macrocytic anemia and iron defi-
ciency may cause microcytic anemia, it was interesting to
investigate whether patients with both vitamin B12 and
iron deficiencies may have macrocytic, normocytic or
microcytic anemia.1,2,6,7 In this study, data from 149 pa-
tients with both vitamin B12 and iron deficiencies were
retrospectively collected from our oral mucosal disease
clinic. We tried to find what percentages of this specific
group of patients might have macrocytic or microcytic
anemia, high, normal, or low MCV, high serum homocys-
teine level, serum GPCA positivity, and specific oral
manifestations.Materials and methods
Patients
In this study, oral mucosal disease patients with vitamin B12
deficiencies were defined as those having a serum vitamin
B12 level  450 pg/mL and patients with iron deficiency
were defined as those having a serum iron level  70 mg/dL
for men, and  65 mg/dL for women. These vitamin B12 and
iron concentrations were chosen because they were the
cut-off point concentrations for giving vitamin B12 or iron
supplement treatment to patients with either vitamin B12
or iron deficiency.15,16 Based on the above selected con-
centrations for vitamin B12 and iron deficiencies, 149 pa-
tients (44 men and 105 women, age range 18e90 years,
mean 54.3  16.6 years) with both vitamin B12 ( 450 pg/
mL) and iron deficiencies (serum iron level  70 mg/dL for
men, and  65 mg/dL for women) were collected. For each
patient, one age- (2 years of each patient’s age) and sex-
matched healthy control subject was selected. Thus, the
normal control group consisted of 149 healthy control pa-
tients (44 men and 105 women, age range 19e89 years,
mean 55.7  13.9 years). All patients and healthy control
subjects were seen consecutively, diagnosed, treated, and
selected in the oral mucosal disease clinic or dental clinic
of National Taiwan University Hospital (NTUH) from July
2007 to June 2014. The 149 patients with both vitamin B12
and iron deficiencies had one or two oral mucosal diseases
including BMS, AG, RAU, and OLP. BMS was diagnosed when
patients had a burning sensation of the oral mucosa in the
absence of clinically apparent mucosal alterations.8,15 Pa-
tients were diagnosed as having partial or complete AG
when their dorsal tongues showed partial or complete
absence or flattening of filiform papillae.10,16 RAU was
diagnosed when patients had at least one episode of oral
ulcerations per month during the preceding years.9 OLP was
diagnosed according to the following criteria: (1) a typical
clinical presentation of radiating grayish-white Wickham
striae or papules (nonerosive OLP) combined with erosion
or ulceration on the bilateral buccal or vestibular mucosa
(erosive OLP), and (2) biopsy specimens characteristic of
OLP, that is, hyperkeratosis or parakeratosis, a slightly
acanthotic epithelium with liquefaction degeneration of
the basal epithelial cells, a pronounced band-like lympho-
cytic infiltrate in the lamina propria, and the absence of
epithelial dysplasia.11 However, all patients with areca quid
chewing habit, autoimmune diseases (such as systemic
lupus erythematosus, rheumatoid arthritis, Sjogren’s syn-
drome, pemphigus vulgaris, and cicatricial pemphigoid),
inflammatory diseases, malignancy, or recent surgery were
excluded. In addition, all patients with serum creatinine
concentrations indicative of renal dysfunction (i.e., men
>131 mM; women >115 mM), and who reported a history of
stroke, heavy alcohol use, or diseases of the liver, kidney,
or coronary arteries were also excluded.17 Healthy control
subjects had either dental caries or mild periodontal dis-
eases but did not have any oral mucosal or systemic dis-
eases. None of our patients with both vitamin B12 and iron
deficiencies had taken any prescription medication for BMS,
AG, RAU, or OLP at least 3 months before entering the
study.
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149 patients with both vitamin B12 and iron deficiencies
included 59 with BMS only, 46 with AG only, 14 with OLP
only, 13 with both OLP and AG, nine with both RAU and BMS,
and eight with both RAU and AG. For all patients with both
vitamin B12 and iron deficiencies and healthy control sub-
jects, oral manifestations including a burning sensation and
numbness of the oral mucosa, dry mouth, taste dysfunc-
tion, AG, RAU, and OLP were inquired, examined, and
recorded. Blood samples were drawn from all patients and
healthy control subjects for measurement of complete
blood count, blood iron, vitamin B12, folic acid, and ho-
mocysteine concentrations. In addition, the presence of
GPCA in sera of patients and healthy control subjects was
also checked. All patients and healthy control subjects
signed the informed consents before entering the study.
This study was reviewed and approved by the Institutional
Review Board at the NTUH.
Determination of complete blood count and blood
iron, vitamin B12, folic acid, and homocysteine
concentrations
Complete blood count and blood iron, vitamin B12, folic
acid, and homocysteine concentrations were determined
by routine tests performed in the Department of Laboratory
Medicine at NTUH.
Determination of serum gastric parietal cell
antibody level
Serum GPCA levels were detected using an indirect immu-
nofluorescence technique with rat stomach as a substrate
as described previously.10,14 In brief, 5 mm cryostat sections
of substrate tissues on slides were reacted with serially
diluted patients’ and control subjects’ sera in a moist
chamber at room temperature for 30 minutes. The initial
dilution of the patients’ and control subjects’ sera was 1:20
with phosphate-buffered saline (PBS). After washing, the
sections were incubated with fluorescein isothiocyanate
(FITC)-labeled goat anti-human IgG antiserum (Boehringer
Mannheim Biochemicals, Indianapolis, IN, USA) which had
been prediluted and kept in a dropper vial by the manu-
facturer and was ready to use, for another 30 minutes. The
sections were washed again, mounted with buffered glyc-
erine, and examined with an Olympus fluorescence micro-
scope (Olympus, Tokyo, Japan). Sera were scored as
positive when they produced fluorescence at a dilution of
20-fold or more.
Statistical analysis
Comparisons of the MCV and mean blood levels of Hb, iron,
vitamin B12, folic acid, and homocysteine between 149
patients with both vitamin B12 and iron deficiencies and 149
age- and sex-matched healthy control subjects or between
any two subgroups were performed using the Student t test.
The differences in the frequency of Hb, vitamin B12, or folic
acid deficiency, of abnormally high blood homocysteine
level, or of serum GPCA positivity between 149 patients
with both vitamin B12 and iron deficiencies and 149 age- andsex-matched healthy control subjects or between any two
subgroups were compared using the Chi-square test. The
result was considered to be significant if the p value was
less than 0.05.Results
The MCV and mean blood concentrations of Hb, iron,
vitamin B12, folic acid, and homocysteine in 149 patients
with both vitamin B12 and iron deficiencies and in 149 age-
and sex-matched healthy control subjects are shown in
Table 1. Because men usually had higher blood levels of Hb
and iron than women, these two mean levels were calcu-
lated separately for men and women. We found that pa-
tients with both vitamin B12 and iron deficiencies had a
significantly lower mean Hb level (for both men and
women, both p values < 0.001), a significantly lower MCV
(p < 0.001), a significantly lower mean folic acid level
(p < 0.05), and a significantly higher mean blood homo-
cysteine level (p < 0.001) than healthy control subjects
(Table 1).
According to the World Health Organization (WHO)
criteria, men with Hb < 13 g/dL and women with Hb < 12 g/
dL were defined as having Hb deficiency or anemia.6 For
serum iron, vitamin B12, and folic acid levels, this study
chose serum iron levels  70 mg/dL for men and  65 mg/dL
for women as the iron deficiency level, the serum vitamin
B12 level  450 pg/mL (148 pM) as the vitamin B12 deficiency
level, and the folic acid level  6 ng/mL (10 nM) as the folic
acid deficiency level.15,16 In addition, patients with a blood
homocysteine level >12.6 mM (which was the mean blood
homocysteine level of healthy control subjects plus two
standard deviations) were defined as having abnormally
high homocysteine level. By the abovementioned defini-
tions, 54 (36.2%) and 16 (10.7%) of the 149 patients with
both vitamin B12 and iron deficiencies had Hb and folic acid
deficiencies, respectively. Moreover, 44 (29.5%) and 36
(24.2%) patients with both vitamin B12 and iron deficiencies
had abnormally high blood homocysteine level and serum
GPCA positivity, respectively (Table 2). However, only 22
(14.8%), 33 (22.1%), 9 (6.0%), 4 (2.7%), and 3 (2.0%) normal
control subjects had iron, vitamin B12, and folic acid de-
ficiencies, abnormally high blood homocysteine level, and
serum GPCA positivity by the aforementioned criteria,
respectively. Furthermore, patients with both vitamin B12
and iron deficiencies had a significantly higher frequency of
Hb deficiency, of abnormally elevated blood homocysteine
level, and of serum GPCA positivity than healthy control
subjects (all p values < 0.001) (Table 2).
When 149 patients with both vitamin B12 and iron de-
ficiencies were further divided into Group 1 (10 patients
with MCV  100 fL), Group 2 (108 patients with MCV be-
tween 80 fL and 99 fL), and Group 3 (31 patients with
MCV < 80 fL), we found that Group 1 patients had
significantly higher MCV (p < 0.001), lower mean serum
vitamin B12 level (p < 0.001), higher mean serum homo-
cysteine level (p < 0.001), and higher frequency of serum
GPCA positivity (p Z 0.025) than Group 2 patients (Table
3). Moreover, Group 3 patients had significantly lower
mean blood Hb level (p < 0.001 for both men and
women), lower MCV (p Z 0.001), and lower mean serum
Table 1 The mean corpuscular volume (MCV) and mean blood concentrations of hemoglobin (Hb), iron, vitamin B12, folic acid,
and homocysteine in 149 patients with both B12 ( 450 pg/mL) and iron ( 70 mg/dL for men or  65 mg/dL for women) de-
ficiencies, and in 149 age- and sex-matched healthy control subjects.
Patients with both B12 and iron
deficiencies (n Z 149)
Healthy control subjects
(n Z 149)
p Student t test
Mean  SD Range Mean  SD Range
Hb (g/dL)
Men 13.6  1.7 (n Z 44) 7.4e16.4 15.1  0.6 (n Z 44) 13.8e16.3 <0.001a
Women 12.0  1.5 (n Z 105) 7.1e14.7 13.6  0.7 (n Z 105) 12.2e15.2 <0.001a
MCV (fL) 86.8  9.5 55.8e117.4 90.9  3.4 82.4e98.6 <0.001a
Iron (mg/dL)
Men 53.0  14.8 (n Z 44) 11.0e69.0 98.3  23.9 (n Z 44) 65.0e151.0 <0.001a
Women 46.5  16.6 (n Z 105) 10.0e64.0 97.0  27.3 (n Z 105) 60.0e204.0 <0.001a
Vitamin B12 (pg/mL) 316.9  93.4 150.0e449.0 651.9  221.2 259.0e1000.0 <0.001a
Folic acid (ng/mL) 12.0  5.8 2.2e24.0 13.6  5.7 4.1e24.0 0.017a
Homocysteine (mM) 13.8  18.3 3.6e174.0 8.6  2.0 4.3e13.4 <0.001a
a Comparisons of MCV and blood concentrations of Hb, iron, vitamin B12, folic, acid and homocysteine between 149 patients with both
B12 and iron deficiencies, and 149 age- and sex-matched healthy control subjects by Student t test with p < 0.05.
Blood profile of oral disease patients 535iron level (p Z 0.007 for men, and p < 0.001 for women)
than Group 2 patients (Table 3). In addition, Group 1
patients had significantly higher mean blood Hb levels
(p Z 0.035 for women only), higher MCV (p < 0.001),
higher mean serum iron levels (p Z 0.004 for women
only), lower mean serum vitamin B12 levels (p < 0.001),
higher mean serum folic acid levels (p Z 0.026), higher
mean serum homocysteine levels (p < 0.001), and higher
frequency of serum GPCA positivity (p Z 0.040) than
Group 3 patients (Table 3).
Of the 149 patients with both vitamin B12 and iron de-
ficiencies, 135 (90.6%) had a burning sensation of the oral
mucosa, 110 (73.8%) had a dry mouth, 67 (45.0%) had AG,
52 (34.9%) had numbness of the oral mucosa, 27 (18.1%)
had OLP, 25 (16.8%) had taste dysfunction, and 17 (11.4%)
had RAU. However, none of healthy control subjects had
any of the aforementioned oral manifestations or
diseases.Table 2 Number and percentage of individuals with hemogl
abnormally high homocysteine level, or with serum gastric parieta
and iron deficiencies, and in 149 age- and sex-matched healthy c
Factor
Patients
iron defi
Hb deficiency (men < 13 g/dL, women < 12 g/dL) 54 (36.
Iron deficiency (men  70 mg/dL, women  65 mg/dL) 149 (100
Vitamin B12 deficiency ( 450 pg/mL) 149 (100
Folic acid deficiency ( 6 ng/mL) 16 (10.
High homocysteine level (>12.6 mM)b 44 (29.
GPCA positivity 36 (24.
a Comparison of the frequency of Hb, iron, vitamin B12 or folic acid
serum GPCA positivity between 149 patients with both B12 and iron de
using the Chi-square test with p < 0.001.
b High homocysteine levels were defined as patients with homocys
healthy control subjects plus two standard deviations.Discussion
This study found that 54 (36.2%) of the 149 oral mucosal
disease patients with both vitamin B12 (serum vitamin B12
level  450 pg/mL) and iron (serum iron level  70 mg/dL
for men, and  65 mg/dL for women) deficiencies had
anemia (men with Hb < 13 g/dL, and women with
Hb < 12 g/dL).6 Moreover, only 36 (24.2%) of the 149 pa-
tients with both vitamin B12 and iron deficiencies were
serum GPCA-positive. Our previous study discovered that 35
(38.9%) and 43 (47.8%) out of 90 patients with vitamin B12
deficiency (serum vitamin B12 level <200 pg/mL) had ane-
mia and serum GPCA-positivity, respectively (unpublished
data). The significantly higher frequency of patients with
serum GPCA-positivity in our previous study was due to the
use of stricter criteria for patient selection in our previous
study (serum vitamin B12 level <200 pg/mL) than in this
study (serum vitamin B12 level  450 pg/mL). The reason
we used a serum vitamin B12 level  450 pg/mL as aobin (Hb), iron, vitamin B12, or folic acid deficiency, with
l cell antibody (GPCA) positivity in 149 patients with both B12
ontrol subjects.
Subject number (%) p Chi-square test
with both B12 and
ciencies (n Z 149)
Healthy control
subjects (n Z 149)
2) 0 (0) <0.001a
.0) 22 (14.8) <0.001a
.0) 33 (22.1) <0.001a
7) 9 (6.0) 0.210
5) 4 (2.7) <0.001a
2) 3 (2.0) <0.001a
deficiency, of abnormally high blood homocysteine level, or of
ficiencies, and 149 age- and sex-matched healthy control subjects
teine levels greater than the mean serum homocysteine level of
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536 J.Y.-F. Chang et al.criterion for patient selection in this study was that this
vitamin B12 level is the cut-off point concentration where
we start to treat patients with vitamin B12 deficiency in our
previous studies.15,16 Furthermore, the use of a relatively
loose criterion of serum vitamin B12 level for patient se-
lection can increase the sample size of patients to obtain
more significant data.
In our 36 GPCA-positive patients, the vitamin B12 defi-
ciency could be attributed to the presence of GPCA,
because the intestinal absorption of vitamin B12 is GPCA-
dependent.1,2 Therefore, the vitamin B12 deficiency in the
other 113 GPCA-negative patients may be due to other
causes including inadequate intake or malabsorption of
vitamin B12, the presence of anti-intrinsic factor anti-
bodies, or transcobalamin II deficiency, etc.2
This study divided our 149 patients with both vitamin
B12 and iron deficiencies into three groups according to the
patients’ MCV level. We found that 10 patients (Group 1)
had macrocytosis (MCV  100 fL), 108 patients (Group 2)
had a relatively normal MCV (between 80 fL and 99 fL), and
31 patients (Group 3) had microcytosis (MCV < 80 fL). We
also discovered that compared with Group 2 (normal MCV)
patients, Group 1 (macrocytosis) patients tended to have
severe vitamin B12 deficiency, high serum homocysteine
level, and a high frequency of GPCA positivity but tended
not to have severe anemia and severe iron deficiency, and
Group 3 (microcytosis) patients were prone to having se-
vere anemia and severe iron deficiency but not to having a
high serum homocysteine level and a high frequency of
GPCA positivity. These findings suggest that GPCA positiv-
ity is an important factor leading to severe vitamin B12
deficiency which in turn causes high serum homocysteine
levels as seen in Group 1 patients. Furthermore, severe
iron deficiency is responsible for the severe anemic status
seen in Group 3 patients. Because vitamin B12 deficiency
can result in the generation of macrocytic RBCs,18e20 the
macrocytic RBCs in our 10 macrocytosis patients are
probably due to severe vitamin B12 deficiency. Moreover,
iron deficiency can lead to the production of microcytic
RBCs6,7 and thus the microcytic RBCs in our 31 microcytosis
patients are probably due to severe iron deficiency. The
MCV of the resting 108 patients with moderate vitamin B12
and iron deficiencies was within normal limits, because
this specific group of patients may produce relatively
normal-sized RBCs or generate nearly equal numbers of
macrocytic or microcytic RBCs. In this study, approxi-
mately 90% of our patients had a normal or higher blood
level of folic acid that might also reduce the vitamin B12-
deficient effect on causing macrocytosis18e20 and further
explain why 72.5% of our 149 patients had an MCV that fell
into the normal limits.
Higher blood homocysteine levels can cause oxidative
stress, damage endothelium, and enhance thrombogenicity
in experimental studies, and thus are associated with
increased rates of coronary heart disease and stroke.21e25
This was the reason why we studied the blood homocyste-
ine levels in our oral mucosal disease patients with both
vitamin B12 and iron deficiencies. Homocysteine is a sulfur-
containing amino acid which is formed during methionine
metabolism.21 Both vitamin B12 and folic acid act as co-
enzymes for the conversion of homocysteine to methio-
nine.26 Therefore, patients with either vitamin B12 or folic
Blood profile of oral disease patients 537acid deficiency can lead to high homocysteine levels in
their sera.21,22 Moreover, the high blood homocysteine
levels in patients was found to be due to deficiencies in
folic acid, vitamin B12, and vitamin B6, because a supple-
ment therapy with folic acid, vitamin B12, and vitamin B6
can reduce blood homocysteine levels in patients.15,16,22 In
this study, an abnormally higher blood homocysteine level
was detected in 44 (29.5%) of the 149 patients with both
vitamin B12 and iron deficiencies. The high blood homo-
cysteine level in this particular group of 44 patients was
probably due to severe vitamin B12 deficiency and the
presence of GPCA in their sera.1,2,22 Moreover, only 10.7% of
our 149 patients with both vitamin B12 and iron deficiencies
had folic acid deficiency. Sufficient blood levels of folic acid
in the majority of our patients may partially explain why
the other 105 patients do not have abnormally high homo-
cysteine levels in their sera.15,16,22
For oral manifestations in our 149 patients with both
vitamin B12 and iron deficiencies, 135 (90.6%) had a
burning sensation of the oral mucosa, 110 (73.8%) had a dry
mouth, 67 (45.0%) had AG, 52 (34.9%) had numbness of the
oral mucosa, 27 (18.1%) had OLP, 25 (16.8%) had taste
dysfunction, and 17 (11.4%) had RAU. Our previous studies
found burning sensation of the oral mucosa, dry mouth,
numbness of the oral mucosa, and taste dysfunction in
100%, 75.7%, 43.9%, and 19.8% of 399 BMS patients,
respectively,8 and in 100%, 79.0%, 57.4%, and 27.8% of 176
AG patients, respectively.10 Because 45.6%, 45.0%, 18.1%,
and 11.4% of our 149 patients with both vitamin B12 and
iron deficiencies had concomitant BMS, AG, OLP, and RAU,
respectively, this could explain why our 149 patients with
both vitamin B12 and iron deficiencies had high or rela-
tively high frequencies of burning sensation of the oral
mucosa, dry mouth, and numbness of the oral mucosa. In
addition, 36.2% of our 149 patients with both vitamin B12
and iron deficiencies had anemia according to the WHO
criteria.6 Anemic patients have reduced Hb which carry
insufficient oxygen to oral mucosa and finally result in
atrophy of oral mucosa.12 Moreover, all of our 149 patients
had both iron and vitamin B12 deficiencies. Iron is essential
to the normal functioning of oral epithelial cells12 and
vitamin B12 plays an important role in DNA synthesis and
cell division.1,17e20 Oral epithelial cells have a high turn-
over rate. Therefore, deficiencies of both iron and vitamin
B12 may result in oral epithelial atrophy. Furthermore, high
blood homocysteine level may result in an elevated fre-
quency of thrombosis in feeding arterioles that supply the
nutrients to the oral epithelial cells.21e25 This in turn leads
to oral epithelial atrophy. Atrophic tongue dorsal or other
oral mucosa in some of our patients could partially explain
why a significant number of our patients had a burning
sensation and numbness the of oral mucosa and taste
dysfunction.10 The reasons why BMS and AG patients may
have a burning sensation and numbness of the oral mu-
cosa, dry mouth, and taste dysfunction compared with
healthy control subjects have been explained in detail in
our previous papers.8,10
Our results demonstrated that 36.2% and 10.7% of our
149 patients with both vitamin B12 and iron deficiencies had
deficiencies of Hb and folic acid, respectively. Moreover,
29.5% and 24.2% of our 149 patients with both vitamin B12
and iron deficiencies had abnormally high bloodhomocysteine levels and serum GPCA positivity, respec-
tively. We also found significantly higher frequencies of Hb
deficiency, of abnormally elevated blood homocysteine
levels, and of GPCA positivity in our 149 patients with both
vitamin B12 and iron deficiencies than in the 149 healthy
control subjects. Because 72.5% of our 149 patients with
both vitamin B12 and iron deficiencies had an MCV that fell
within normal limits, the MCV level was not a good indicator
to assess the anemic status of patients with both vitamin
B12 and iron deficiencies.References
1. Lahner E, Annibale B. Pernicious anemia: new insights from a
gastroenterological point of view. World J Gastroenterol 2009;
15:5121e8.
2. Oh RC, Brown DL. Vitamin B12 deficiency. Am Fam Phys 2003;
67:979e86.
3. Taylor KB, Roitt IM, Doniach D, Coushman KG, Shapland C.
Autoimmune phenomena in pernicious anemia: gastric anti-
bodies. BMJ 1962;2:1347e52.
4. Snow CF. Laboratory diagnosis of vitamin B12 and folate defi-
ciency. A guide for the primary care physician. Arch Intern Med
1999;159:1289e98.
5. Taylor KB. Inhibition of intrinsic factor by pernicious anaemia
sera. Lancet 1959;2:106e8.
6. WHO/UNICEF/UNU. Iron deficiency anaemia assessment, pre-
vention, and control: a guide for programme managers.
Geneva, Switzerland: World Health Organization; 2001.
7. Shine JW. Microcytic anemia. Am Fam Physician 1997;55:
2455e62.
8. Lin HP, Wang YP, Chen HM, Kuo YS, Lang MJ, Sun A. Significant
association of hematinic deficiencies and high blood homo-
cysteine levels with burning mouth syndrome. J Formos Med
Assoc 2013;112:319e25.
9. Sun A, Chen HM, Cheng SJ, Wang YP, Chang JYF, Wu YC, et al.
Significant association of deficiency of hemoglobin, iron,
vitamin B12, and folic acid and high homocysteine level with
recurrent aphthous ulceration. J Oral Pathol Med 2015;44:
300e5.
10. Sun A, Lin HP, Wang YP, Chiang CP. Significant association of
deficiency of hemoglobin, iron and vitamin B12, high homo-
cysteine level, and gastric parietal cell antibody positivity with
atrophic glossitis. J Oral Pathol Med 2012;41:500e4.
11. Chen HM, Wang YP, Chang JYF, Wu YC, Cheng SJ, Sun A.
Significant association of deficiencies of hemoglobin, iron, folic
acid, and vitamin B12 and high homocysteine level with oral
lichen. J Formos Med Assoc 2015;114:124e9.
12. Wu YC, Wang YP, Chang JYF, Cheng SJ, Chen HM, Sun A. Oral
manifestations and blood profile in patients with iron defi-
ciency anemia. J Formos Med Assoc 2014;113:83e7.
13. Wang YP, Chang JYF, Wu YC, Cheng SJ, Chen HM, Sun A. Oral
manifestations and blood profile in patients with thalassemia
trait. J Formos Med Assoc 2013;112:761e5.
14. Sun A, Wang YP, Lin HP, Jia JS, Chiang CP. Do all the patients
with gastric parietal cell antibodies have pernicious anemia?
Oral Dis 2013;19:381e6.
15. Sun A, Lin HP, Wang YP, Chen HM, Cheng SJ, Chiang CP. Sig-
nificant reduction of serum homocysteine level and oral
symptoms after different vitamin supplement treatments in
patients with burning mouth syndrome. J Oral Pathol Med
2013;42:474e9.
16. Sun A, Wang YP, Lin HP, Chen HM, Cheng SJ, Chiang CP. Sig-
nificant reduction of homocysteine level with multiple B vita-
mins in atrophic glossitis patients. Oral Dis 2013;19:519e24.
538 J.Y.-F. Chang et al.17. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate
and vitamin B12 status in relation to anemia, macrocy-
tosis, and cognitive impairment in older Americans in the
age of folic acid fortification. Am J Clin Nutr 2007;85:
193e200.
18. Veda P. Evaluation of macrocytosis in routine hemograms. In-
dian J Hematol Blood Transfus 2013;29:26e30.
19. Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam
Physician 2009;79:203e8.
20. Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other
causes of macrocytosis. Clin Med Res 2006;4:236e41.
21. Spence JD. Homocysteine-lowering therapy: a role in stroke
prevention? Lancet Neurol 2007;6:830e8.22. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al.
Homocysteine lowering with folic acid and B vitamins in
vascular disease. N Engl J Med 2006;354:1567e77.
23. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N
Engl J Med 1998;338:1042e50.
24. Harker LA, Harlan JM, Ross R. Effect of sulfinpyrazone on ho-
mocysteine induced endothelial injury and arteriosclerosis in
baboons. Circ Res 1983;53:731e9.
25. Harker LA, Slichter SJ, Scott CR, Ross R. Homocysteinemia:
vascular injury and arterial thrombosis. N Engl J Med 1974;291:
537e43.
26. Chanarin I, Deacon R, Lumb M, Perry J. Cobalamin-folate in-
terrelations. Blood Rev 1989;3:211e5.
